Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs PROCTER & GAMBLE HEALTH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN PROCTER & GAMBLE HEALTH LUPIN/
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x 40.7 34.5 118.2% View Chart
P/BV x 6.0 10.5 56.9% View Chart
Dividend Yield % 0.2 2.0 12.2%  

Financials

 LUPIN   PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    LUPIN
Mar-23
PROCTER & GAMBLE HEALTH
Jun-23
LUPIN/
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs7995,366 14.9%   
Low Rs5833,883 15.0%   
Sales per share (Unadj.) Rs365.8740.7 49.4%  
Earnings per share (Unadj.) Rs9.8138.2 7.1%  
Cash flow per share (Unadj.) Rs29.2155.2 18.8%  
Dividends per share (Unadj.) Rs4.0095.00 4.2%  
Avg Dividend yield %0.62.1 28.2%  
Book value per share (Unadj.) Rs270.7447.6 60.5%  
Shares outstanding (eoy) m454.9816.60 2,740.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.96.2 30.3%   
Avg P/E ratio x70.233.5 209.9%  
P/CF ratio (eoy) x23.729.8 79.4%  
Price / Book Value ratio x2.610.3 24.7%  
Dividend payout %40.768.7 59.2%   
Avg Mkt Cap Rs m314,38176,761 409.6%   
No. of employees `000NANA-   
Total wages/salary Rs m30,8722,062 1,497.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m166,41712,296 1,353.4%  
Other income Rs m1,509184 820.6%   
Total revenues Rs m167,92612,480 1,345.5%   
Gross profit Rs m17,2063,247 529.9%  
Depreciation Rs m8,807281 3,134.1%   
Interest Rs m2,7438 35,623.4%   
Profit before tax Rs m7,1653,142 228.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,688847 317.2%   
Profit after tax Rs m4,4772,295 195.1%  
Gross profit margin %10.326.4 39.2%  
Effective tax rate %37.527.0 139.1%   
Net profit margin %2.718.7 14.4%  
BALANCE SHEET DATA
Current assets Rs m124,51311,713 1,063.1%   
Current liabilities Rs m92,6546,791 1,364.4%   
Net working cap to sales %19.140.0 47.8%  
Current ratio x1.31.7 77.9%  
Inventory Days Days26263 10.0%  
Debtors Days Days98343 28.6%  
Net fixed assets Rs m103,49010,617 974.8%   
Share capital Rs m910166 548.2%   
"Free" reserves Rs m122,2467,265 1,682.8%   
Net worth Rs m123,1567,431 1,657.4%   
Long term debt Rs m2750-   
Total assets Rs m228,00322,330 1,021.1%  
Interest coverage x3.6409.1 0.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.70.6 132.5%   
Return on assets %3.210.3 30.7%  
Return on equity %3.630.9 11.8%  
Return on capital %8.042.4 18.9%  
Exports to sales %00-   
Imports to sales %013.1 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA1,605 0.0%   
Fx inflow Rs m48,0571,465 3,279.9%   
Fx outflow Rs m21,7521,605 1,354.9%   
Net fx Rs m26,306-140 -18,762.9%   
CASH FLOW
From Operations Rs m18,9722,360 803.9%  
From Investments Rs m-12,868-215 5,985.0%  
From Financial Activity Rs m-3,373-985 342.5%  
Net Cashflow Rs m2,7321,160 235.5%  

Share Holding

Indian Promoters % 46.8 0.0 -  
Foreign collaborators % 0.3 51.8 0.5%  
Indian inst/Mut Fund % 45.8 20.3 226.3%  
FIIs % 16.1 7.6 212.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.0 48.2 109.9%  
Shareholders   281,542 56,730 496.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Lupin vs Procter & Gamble Health

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Lupin vs Procter & Gamble Health Share Price Performance

Period Lupin Procter & Gamble Health S&P BSE HEALTHCARE
1-Day 1.23% -0.55% 1.18%
1-Month 0.15% -7.47% -0.75%
1-Year 151.14% -3.02% 61.82%
3-Year CAGR 17.13% -9.12% 18.16%
5-Year CAGR 17.42% 5.75% 19.79%

* Compound Annual Growth Rate

Here are more details on the Lupin share price and the Procter & Gamble Health share price.

Moving on to shareholding structures...

The promoters of Lupin hold a 47.0% stake in the company. In case of Procter & Gamble Health the stake stands at 51.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Lupin and the shareholding pattern of Procter & Gamble Health.

Finally, a word on dividends...

In the most recent financial year, Lupin paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 40.7%.

Procter & Gamble Health paid Rs 95.0, and its dividend payout ratio stood at 68.7%.

You may visit here to review the dividend history of Lupin, and the dividend history of Procter & Gamble Health.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.